Enovix (NASDAQ:ENVX) Shares Down 5.3% – Here’s Why

10 Nov 2025, 16:14 by Scott Moore · The Cerbat Gem

Shares of Enovix Corporation (NASDAQ:ENVX – Get Free Report) fell 5.3% on Monday . The stock traded as low as $9.01 and last traded at $9.0550. 2,971,068 shares changed hands during mid-day trading, a decline of 57% from the average session volume of 6,929,317 shares. The stock had previously closed at $9.56.

Analyst Ratings Changes

Several brokerages have issued reports on ENVX. Canaccord Genuity Group dropped their target price on shares of Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Thursday. Oppenheimer set a $24.00 price target on shares of Enovix in a research report on Thursday. Cantor Fitzgerald cut their price objective on shares of Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday. Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a research note on Friday, October 31st. Finally, Benchmark increased their target price on Enovix from $15.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, July 25th. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.89.

Get Our Latest Stock Analysis on Enovix

Enovix Stock Down 3.3%

The company has a 50-day moving average of $10.80 and a 200-day moving average of $10.25. The company has a current ratio of 9.72, a quick ratio of 9.47 and a debt-to-equity ratio of 1.74. The company has a market capitalization of $2.00 billion, a price-to-earnings ratio of -11.41 and a beta of 2.09.

Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The company reported ($0.13) earnings per share for the quarter. The business had revenue of $7.47 million for the quarter. Enovix had a negative return on equity of 61.78% and a negative net margin of 525.93%. On average, equities analysts predict that Enovix Corporation will post -1.01 earnings per share for the current fiscal year.

Insider Activity at Enovix

In other news, COO Ajay Marathe sold 18,614 shares of the business’s stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $13.00, for a total transaction of $241,982.00. Following the sale, the chief operating officer directly owned 1,002,684 shares of the company’s stock, valued at $13,034,892. The trade was a 1.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 14.10% of the company’s stock.

Institutional Investors Weigh In On Enovix

Institutional investors and hedge funds have recently modified their holdings of the company. Kingstone Capital Partners Texas LLC purchased a new stake in Enovix in the second quarter valued at approximately $13,206,000. Electron Capital Partners LLC lifted its stake in Enovix by 18.6% during the 1st quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company’s stock valued at $49,272,000 after acquiring an additional 1,054,029 shares during the period. CenterBook Partners LP lifted its stake in Enovix by 71.0% during the 1st quarter. CenterBook Partners LP now owns 1,736,570 shares of the company’s stock valued at $12,746,000 after acquiring an additional 721,309 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Enovix by 65.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock valued at $8,351,000 after acquiring an additional 449,934 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Enovix in the first quarter worth $3,030,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)